10-Q: Edgewell Reports Q1 Loss Amid Divestiture & Restructuring
Quarterly Report
Edgewell Personal Care Company reported a significant net loss in Q1 fiscal 2026, primarily driven by a goodwill impairment charge related to its Feminine Care divestiture and increased restructuring costs.
Summary
- Net sales from continuing operations increased by 1.9% to $422.8 million for the three months ended December 31, 2025, compared to $415.1 million in the prior year quarter.
- Organic net sales, excluding currency impacts, decreased by 0.5% ($1.9 million).
- The company reported a net loss from continuing operations of $(29.2) million, a significant decline from $(10.1) million in the prior year quarter.
- Total net loss for the period was $(65.7) million, compared to $(2.1) million in the prior year, largely due to a $(36.5) million loss from discontinued operations.
- Loss from discontinued operations includes a goodwill impairment charge of $37.4 million and a loss on assets held for sale of $3.8 million related to the Feminine Care segment divestiture.
- Diluted loss per share from continuing operations was $(0.63), worsening from $(0.21) in the prior year quarter.
- Gross profit decreased by $11.5 million, or 6.7%, to $161.0 million, with gross margin falling 350 basis points to 38.1%.
- Restructuring charges significantly increased to $18.1 million from $4.1 million in the prior year, with approximately $65 million in pre-tax charges expected for fiscal 2026.
- The Feminine Care segment was sold to Essity for approximately $340.0 million, with the transaction closing on February 2, 2026, and proceeds used to repay outstanding borrowings under the U.S. Revolving Credit Facility.
- Wet Shave segment net sales decreased organically by 3.9%, while Sun and Skin Care segment net sales increased organically by 8.0%.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing negatively due to the substantial net loss, significant goodwill impairment, and declining gross margins, despite the strategic divestiture and some organic growth in specific segments.
Positives
- Net sales from continuing operations increased by 1.9% to $422.8 million, driven by a $9.6 million favorable currency impact.
- Organic sales growth in North America was 0.7%, with strong volume growth in Sun Care and Grooming, including nearly 27% growth in Cremo.
- Sun and Skin Care segment net sales increased organically by 8.0% to $131.5 million, primarily due to 19.5% growth in Sun Care volumes in North America.
- The divestiture of the Feminine Care segment for $340.0 million is a strategic step to transform the company into a more focused personal care company, with proceeds used to repay debt.
- Productivity savings contributed approximately 240 basis points to gross margin, partially offsetting inflationary pressures.
Negatives
- The company reported a total net loss of $(65.7) million, a substantial increase from $(2.1) million in the prior year quarter.
- Net loss from continuing operations worsened to $(29.2) million from $(10.1) million in the prior year quarter.
- Diluted loss per share from continuing operations was $(0.63), compared to $(0.21) in the prior year.
- Gross profit decreased by $11.5 million, or 6.7%, and gross margin declined by 350 basis points to 38.1%.
- Adjusted gross margin decreased by 210 basis points, primarily due to 450 basis points of core inflation, tariffs, volume absorption, and 75 basis points of unfavorable mix.
- Restructuring charges increased significantly to $18.1 million from $4.1 million in the prior year, impacting operating income.
- Loss from discontinued operations, net of tax, was $(36.5) million, including a $37.4 million goodwill impairment charge and a $3.8 million loss on assets held for sale related to the Feminine Care segment.
- Wet Shave segment organic net sales decreased by 3.9%, with North America declining 8.3% due to decreased volumes and increased promotional levels.
- Sun and Skin Care segment reported an increased loss of $(3.6) million, up from $(3.4) million in the prior year, driven by higher marketing expenses.
- Net cash used for operating activities increased to $(125.9) million from $(115.6) million in the prior year, largely due to changes in net working capital and lower earnings.
Risks
- Intense competition in products, prices, and costs within the industry.
- Potential loss of principal customers or changes in their policies.
- Inability to design and execute a successful omnichannel strategy.
- Fluctuations in the price and supply of raw materials and costs of labor, warehousing, and transportation.
- Impact of seasonal volatility on sales, financial performance, working capital requirements, and cash flow.
- Ability to successfully manage evolving global financial risks, including tariffs, foreign currency fluctuations, currency exchange or pricing controls, and localized volatility.
- Level of indebtedness and related covenants, and ability to generate sufficient income and cash flow for share repurchases and dividend payments.
- Failure to maintain brand reputation and successfully respond to changing consumer habits, perceptions of ingredients, negative perceptions of packaging, or lack of recyclability.
- Access to capital markets and borrowing capacity.
- Impairment of goodwill and other intangible assets.
- Ability to successfully manage financial, legal, reputational, and operational risks associated with third-party relationships (suppliers, contract manufacturers, distributors).
- Risks associated with international operations.
- Ability to effectively integrate acquired companies and successfully manage divestiture activities.
- Ability to successfully implement cost savings initiatives, including rationalization or restructuring efforts.
- Ability to rely on and maintain key Company and third-party information and operational technology systems, networks, and services, and maintain data security.
- Ability to successfully achieve, maintain, or adjust environmental or sustainability goals and priorities.
- Ability to successfully manage current and expanding regulatory and legal requirements and matters (product liability, intellectual property, labor, tax, environment, cybersecurity).
- Ability to adequately protect intellectual property rights.
- Product quality and safety issues, including recalls and product liability.
- Losses or increased funding and expenses related to pension plans.
Future Outlook
The company expects to incur approximately $65 million in pre-tax restructuring and related charges in fiscal 2026 as it continues to strengthen its operating model, simplify the organization, and improve manufacturing and supply chain efficiency. The consolidation of Mexico facilities is expected to be completed by the third quarter of fiscal 2026, and the consolidation of Wet Shave operations by the first quarter of fiscal 2028. Proceeds from the Feminine Care divestiture are expected to be used for continued investment in core brands, capital expenditures, and other growth initiatives, with approximately $55 million in cash taxes anticipated on the tax gain from the sale. The company believes its cash on hand, divestiture proceeds, cash flows from operations, and borrowing capacity will be sufficient for liquidity needs for at least the next 12 months.
Management Comments
- The divestiture of the Feminine Care segment is a key step to transform Edgewell into a more focused, agile, and consumer-driven personal care company.
- Organic sales growth in North America was 0.7%, driven by volume growth in Sun Care and Grooming, partially offset by lower volumes and unfavorable pricing in Wet Shave and Skin Care.
- Organic sales in international markets declined 1.6%, largely driven by volume declines in Sun Care and Wet Shave, primarily reflecting an anticipated change in the quarterly phasing of Wet Shave sales in Japan, and Sun Care sales in distributor markets.
- The increase in interest expense was the result of higher borrowing levels on the company's U.S. Revolving Credit Facility.
- The loss in the first quarter of 2026 primarily includes the impact of the goodwill impairment charge of $37.4 million and loss on held-for-sale of $3.8 million.
Industry Context
StockSavvy.ai notes that Edgewell's strategic divestiture of its Feminine Care segment aligns with a broader industry trend of consumer goods companies streamlining portfolios to focus on core, higher-growth categories. While the immediate financial impact includes significant impairment charges, the long-term goal is to enhance agility and consumer-centricity. The mixed organic sales performance, with growth in Sun Care and Grooming offsetting declines in Wet Shave and Skin Care, reflects the dynamic and competitive nature of the personal care market, where innovation and brand relevance are crucial. The ongoing restructuring initiatives are common across mature industries seeking efficiency gains amidst inflationary pressures.
Comparison to Industry Standards
- NA
Legal Proceedings
- The company and its subsidiaries are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business.
- The amount of liability, if any, from these proceedings cannot be determined with certainty, but the company believes it is not reasonably likely to be material to its financial position, results of operations, or cash flows.
Stakeholder Impact
- Shareholders are negatively impacted by the significant net loss and diluted loss per share, although the strategic divestiture aims for long-term focus.
- Employees may be affected by ongoing restructuring and consolidation efforts, particularly those in Mexico and Wet Shave operations.
- Creditors benefit from the repayment of outstanding borrowings under the U.S. Revolving Credit Facility using divestiture proceeds, improving the company's debt profile.
Next Steps
- Finalize the calculation of the loss on assets held for sale upon deconsolidation of the net assets of the Feminine Care disposal group in the second quarter of fiscal 2026.
- Provide certain services to Essity under a Transition Services Agreement for an initial duration of twelve months following the Feminine Care divestiture, with costs recorded in continuing operations.
- Continue actions to strengthen the operating model, simplify the organization, and improve manufacturing and supply chain efficiency and productivity, incurring approximately $65 million in restructuring and related charges in fiscal 2026.
- Complete the consolidation of Mexico facilities by the third quarter of fiscal 2026.
- Complete the consolidation of Wet Shave operations by the first quarter of fiscal 2028.
- Utilize proceeds from the Feminine Care sale for continued investment in core brands, capital expenditures, and other growth initiatives.
- Pay a quarterly cash dividend of $0.15 per common share on April 8, 2026, to shareholders of record as of March 6, 2026.
- Monitor cash flows, spending, and liquidity needs, relying on cash on hand, divestiture proceeds, operating cash flows, and revolving credit facility capacity.
Key Dates
| Date | Description |
|---|---|
| August 5, 2025 | Quarterly cash dividend of $0.15 per common share declared. |
| September 4, 2025 | Record date for the quarterly cash dividend declared on August 5, 2025. |
| September 30, 2025 | Fiscal year end for which the company's annual report on Form 10-K was filed. |
| October 8, 2025 | Payable date for the quarterly cash dividend declared on August 5, 2025. |
| November 12, 2025 | Agreement entered into to sell the Feminine Care segment to Essity. |
| November 13, 2025 | Board approved a new share repurchase authorization of up to $100.0 million, superseding the previous authorization. Also, a quarterly cash dividend of $0.15 per common share was declared. |
| November 18, 2025 | Date the company's Annual Report on Form 10-K for the fiscal year ended September 30, 2025, was filed with the SEC. |
| December 3, 2025 | Record date for the quarterly cash dividend declared on November 13, 2025. |
| December 31, 2025 | End of the quarterly period covered by this Form 10-Q filing. |
| January 8, 2026 | Payable date for the quarterly cash dividend declared on November 13, 2025. |
| January 31, 2026 | Latest practicable date for common shares outstanding (46,716,605 shares). |
| February 2, 2026 | Closing date of the sale of the Feminine Care segment to Essity, with proceeds of approximately $340.0 million received. |
| February 5, 2026 | Board declared a quarterly cash dividend of $0.15 per common share for the first fiscal quarter of 2026. |
| February 9, 2026 | Date of certification by the Chief Executive Officer and Chief Financial Officer for this Form 10-Q. |
| March 6, 2026 | Record date for the quarterly cash dividend declared on February 5, 2026. |
| April 8, 2026 | Payable date for the quarterly cash dividend declared on February 5, 2026. |
| 2027 | Contract maturities for foreign currency cash flow hedges extend into fiscal 2027. |
| Q3 Fiscal 2026 | Expected completion of the consolidation of Mexico facilities. |
| Q1 Fiscal 2028 | Expected completion of the consolidation of Wet Shave operations. |
| 2028 | Maturity date for Senior notes with a fixed interest rate of 5.5% ($750.0 million). |
| 2029 | Maturity date for Senior notes with a fixed interest rate of 4.1% ($500.0 million) and the U.S. Revolving Credit Facility. |
| December 15, 2027 | Effective date for ASU No. 2025-06, Intangibles—Goodwill and Other—Internal-Use Software, for fiscal years beginning after this date. |
| December 15, 2026 | Effective date for ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures, for fiscal years beginning after this date. |
| December 15, 2024 | Effective date for ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, for fiscal years beginning after this date. Also, interim disclosures for ASU 2024-03 are required for periods within annual reporting periods beginning after this date. |
Recommendation
holdWhile the company reported a substantial net loss driven by a significant goodwill impairment and increased restructuring costs, the strategic divestiture of the Feminine Care segment and the use of proceeds to reduce debt are positive long-term moves. The mixed segment performance, with growth in Sun and Skin Care offsetting declines in Wet Shave, indicates a transitional period. Investors should hold to observe the execution of restructuring plans and the benefits of a more focused portfolio, as the immediate negative financial impacts are largely non-recurring from the divestiture and ongoing strategic shifts.
Keywords
Personal Care, SEC Filing, 10-Q, Edgewell, EPC, Wet Shave, Sun and Skin Care, Feminine Care Divestiture, Restructuring, Goodwill Impairment, Financial Results, Net Sales, Net Loss, Gross Margin, EPS, Debt, Share Repurchase, Dividends
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.